IV Nitroglycerin Half-Life
Intravenous nitroglycerin has an elimination half-life of approximately 3 minutes 1.
Pharmacokinetic Profile
The extremely short half-life of IV NTG is a defining characteristic that directly impacts its clinical use:
- Volume of distribution: Approximately 3 L/kg
- Clearance rate: Close to 1 L/kg/min (greatly exceeds hepatic blood flow)
- Half-life: About 3 minutes 1
Sites of Metabolism
The rapid clearance occurs because nitroglycerin is metabolized at multiple extrahepatic sites, including:
- Red blood cells
- Vascular walls
- Liver (though clearance exceeds hepatic blood flow alone)
The first metabolic products are inorganic nitrate and 1,2- and 1,3-dinitroglycerols, which are less potent vasodilators but longer-lived in serum 1.
Clinical Implications of the Short Half-Life
Rapid Titration Capability
The 3-minute half-life allows for:
- Quick dose adjustments every 3-5 minutes 2
- Rapid reversal of hypotensive effects if they occur
- Precise hemodynamic control in acute settings
Tolerance Development
Despite the short half-life, tolerance develops within 24 hours of continuous infusion 1. This is a critical pitfall:
- Drug-free intervals of 10-12 hours are necessary to restore efficacy
- Patients requiring IV NTG beyond 24 hours may need periodic dose increases 3, 2
- One study showed nearly complete loss of hemodynamic effect after 48 hours of continuous infusion 1
Dosing Considerations
The ACC/AHA guidelines recommend 4:
- Initial rate: 10 mcg/min
- Titrate by 10 mcg/min every 3-5 minutes
- Common ceiling dose: 200 mcg/min (though higher doses up to 400 mcg/min have been used safely)
The short half-life means steady-state is achieved rapidly (within approximately 15 minutes), allowing clinicians to assess response quickly and adjust accordingly.